Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Oral Mucositis Drugs Market Research Report 2025

Global Oral Mucositis Drugs Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 89 Pages

Report ld: 3471065

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Oral Mucositis Drugs Market Size(US$)

CAGR 2025-2031

7.5%

Market Size,2031

USD 1,708

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,107 million

Market Forecast in 2031(Value)

US$ 1,708 million

CAGR

7.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Oral Mucositis Drugs was valued at US$ 1037 million in the year 2024 and is projected to reach a revised size of US$ 1708 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.

The oral mucositis drugs market is primarily driven by the rising incidence of cancer and the increasing adoption of chemotherapy and radiation treatments, which often lead to oral mucositis as a common side effect. With more cancer patients undergoing aggressive treatments, the demand for effective oral mucositis management is growing. Additionally, advancements in drug formulations, including targeted therapies and biologics, are providing patients with more effective and safer treatment options. Increased awareness about supportive care in cancer therapy, along with research funding from public and private sectors, is also boosting the market’s growth by promoting new drug developments and clinical trials.

Challenges in this market include the high costs associated with drug development and regulatory approvals, which can limit the number of new therapies available. Moreover, the complex nature of oral mucositis and its varied responses to treatment make it difficult to create universally effective drugs, leading to limitations in therapeutic options. Stringent regulatory requirements for safety and efficacy can prolong the time-to-market for new drugs. In addition, competition from alternative supportive care methods, such as oral care products and palliative treatments, presents a further challenge to the widespread adoption of prescription drugs for oral mucositis.

Global Oral Mucositis Drugs key players include 3M Healthcare, GSK, Colgate-Palmolive, etc. Global top three manufacturers hold a share about 20%. Americas is the largest market, with a share about 50%, followed by Asia Pacific and Europe, both have a share about 50 percent. In terms of product, Pain Control Medication is the largest segment, with a share about 65%. And in terms of application, the largest application is Radiotherapy, followed by Chemotherapy, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Oral Mucositis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Mucositis Drugs.

The Oral Mucositis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Mucositis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Mucositis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

3M Healthcare

Haleon

Pfizer

Colgate-Palmolive

Norgine

Sobi

Bausch Health

EUSA Pharma

Camurus

Clinigen Group

Helsinn Healthcare

Alliance Pharma

Amgen

Galera Therapeutics

Helsinn Group

Segment by Type

Mouthwash

Pain Control Medication

Other

Segment by Application

Chemotherapy

Radiotherapy

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Oral Mucositis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Oral Mucositis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Oral Mucositis Drugs Market Overview

1.1 Product Definition

1.2 Oral Mucositis Drugs by Type

1.2.1 Global Oral Mucositis Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Mouthwash

1.2.3 Pain Control Medication

1.2.4 Other

1.3 Oral Mucositis Drugs by Application

1.3.1 Global Oral Mucositis Drugs Market Value by Application (2024 VS 2031)

1.3.2 Chemotherapy

1.3.3 Radiotherapy

1.4 Global Oral Mucositis Drugs Market Size Estimates and Forecasts

1.4.1 Global Oral Mucositis Drugs Revenue 2020-2031

1.4.2 Global Oral Mucositis Drugs Sales 2020-2031

1.4.3 Global Oral Mucositis Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Oral Mucositis Drugs Market Competition by Manufacturers

2.1 Global Oral Mucositis Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Oral Mucositis Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Oral Mucositis Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Oral Mucositis Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Mucositis Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Mucositis Drugs, Product Type & Application

2.7 Global Key Manufacturers of Oral Mucositis Drugs, Date of Enter into This Industry

2.8 Global Oral Mucositis Drugs Market Competitive Situation and Trends

2.8.1 Global Oral Mucositis Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Oral Mucositis Drugs Players Market Share by Revenue

2.8.3 Global Oral Mucositis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Mucositis Drugs Market Scenario by Region

3.1 Global Oral Mucositis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Oral Mucositis Drugs Sales by Region: 2020-2031

3.2.1 Global Oral Mucositis Drugs Sales by Region: 2020-2025

3.2.2 Global Oral Mucositis Drugs Sales by Region: 2026-2031

3.3 Global Oral Mucositis Drugs Revenue by Region: 2020-2031

3.3.1 Global Oral Mucositis Drugs Revenue by Region: 2020-2025

3.3.2 Global Oral Mucositis Drugs Revenue by Region: 2026-2031

3.4 North America Oral Mucositis Drugs Market Facts & Figures by Country

3.4.1 North America Oral Mucositis Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Oral Mucositis Drugs Sales by Country (2020-2031)

3.4.3 North America Oral Mucositis Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Oral Mucositis Drugs Market Facts & Figures by Country

3.5.1 Europe Oral Mucositis Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Oral Mucositis Drugs Sales by Country (2020-2031)

3.5.3 Europe Oral Mucositis Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Mucositis Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Oral Mucositis Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Oral Mucositis Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Oral Mucositis Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Oral Mucositis Drugs Market Facts & Figures by Country

3.7.1 Latin America Oral Mucositis Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Oral Mucositis Drugs Sales by Country (2020-2031)

3.7.3 Latin America Oral Mucositis Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Mucositis Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Mucositis Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Oral Mucositis Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Oral Mucositis Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Oral Mucositis Drugs Sales by Type (2020-2031)

4.1.1 Global Oral Mucositis Drugs Sales by Type (2020-2025)

4.1.2 Global Oral Mucositis Drugs Sales by Type (2026-2031)

4.1.3 Global Oral Mucositis Drugs Sales Market Share by Type (2020-2031)

4.2 Global Oral Mucositis Drugs Revenue by Type (2020-2031)

4.2.1 Global Oral Mucositis Drugs Revenue by Type (2020-2025)

4.2.2 Global Oral Mucositis Drugs Revenue by Type (2026-2031)

4.2.3 Global Oral Mucositis Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Oral Mucositis Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Oral Mucositis Drugs Sales by Application (2020-2031)

5.1.1 Global Oral Mucositis Drugs Sales by Application (2020-2025)

5.1.2 Global Oral Mucositis Drugs Sales by Application (2026-2031)

5.1.3 Global Oral Mucositis Drugs Sales Market Share by Application (2020-2031)

5.2 Global Oral Mucositis Drugs Revenue by Application (2020-2031)

5.2.1 Global Oral Mucositis Drugs Revenue by Application (2020-2025)

5.2.2 Global Oral Mucositis Drugs Revenue by Application (2026-2031)

5.2.3 Global Oral Mucositis Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Oral Mucositis Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 3M Healthcare

6.1.1 3M Healthcare Company Information

6.1.2 3M Healthcare Description and Business Overview

6.1.3 3M Healthcare Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 3M Healthcare Oral Mucositis Drugs Product Portfolio

6.1.5 3M Healthcare Recent Developments/Updates

6.2 Haleon

6.2.1 Haleon Company Information

6.2.2 Haleon Description and Business Overview

6.2.3 Haleon Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Haleon Oral Mucositis Drugs Product Portfolio

6.2.5 Haleon Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pfizer Oral Mucositis Drugs Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Colgate-Palmolive

6.4.1 Colgate-Palmolive Company Information

6.4.2 Colgate-Palmolive Description and Business Overview

6.4.3 Colgate-Palmolive Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Colgate-Palmolive Oral Mucositis Drugs Product Portfolio

6.4.5 Colgate-Palmolive Recent Developments/Updates

6.5 Norgine

6.5.1 Norgine Company Information

6.5.2 Norgine Description and Business Overview

6.5.3 Norgine Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Norgine Oral Mucositis Drugs Product Portfolio

6.5.5 Norgine Recent Developments/Updates

6.6 Sobi

6.6.1 Sobi Company Information

6.6.2 Sobi Description and Business Overview

6.6.3 Sobi Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sobi Oral Mucositis Drugs Product Portfolio

6.6.5 Sobi Recent Developments/Updates

6.7 Bausch Health

6.7.1 Bausch Health Company Information

6.7.2 Bausch Health Description and Business Overview

6.7.3 Bausch Health Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bausch Health Oral Mucositis Drugs Product Portfolio

6.7.5 Bausch Health Recent Developments/Updates

6.8 EUSA Pharma

6.8.1 EUSA Pharma Company Information

6.8.2 EUSA Pharma Description and Business Overview

6.8.3 EUSA Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 EUSA Pharma Oral Mucositis Drugs Product Portfolio

6.8.5 EUSA Pharma Recent Developments/Updates

6.9 Camurus

6.9.1 Camurus Company Information

6.9.2 Camurus Description and Business Overview

6.9.3 Camurus Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Camurus Oral Mucositis Drugs Product Portfolio

6.9.5 Camurus Recent Developments/Updates

6.10 Clinigen Group

6.10.1 Clinigen Group Company Information

6.10.2 Clinigen Group Description and Business Overview

6.10.3 Clinigen Group Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Clinigen Group Oral Mucositis Drugs Product Portfolio

6.10.5 Clinigen Group Recent Developments/Updates

6.11 Helsinn Healthcare

6.11.1 Helsinn Healthcare Company Information

6.11.2 Helsinn Healthcare Description and Business Overview

6.11.3 Helsinn Healthcare Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Helsinn Healthcare Oral Mucositis Drugs Product Portfolio

6.11.5 Helsinn Healthcare Recent Developments/Updates

6.12 Alliance Pharma

6.12.1 Alliance Pharma Company Information

6.12.2 Alliance Pharma Description and Business Overview

6.12.3 Alliance Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Alliance Pharma Oral Mucositis Drugs Product Portfolio

6.12.5 Alliance Pharma Recent Developments/Updates

6.13 Amgen

6.13.1 Amgen Company Information

6.13.2 Amgen Description and Business Overview

6.13.3 Amgen Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Amgen Oral Mucositis Drugs Product Portfolio

6.13.5 Amgen Recent Developments/Updates

6.14 Galera Therapeutics

6.14.1 Galera Therapeutics Company Information

6.14.2 Galera Therapeutics Description and Business Overview

6.14.3 Galera Therapeutics Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Galera Therapeutics Oral Mucositis Drugs Product Portfolio

6.14.5 Galera Therapeutics Recent Developments/Updates

6.15 Helsinn Group

6.15.1 Helsinn Group Company Information

6.15.2 Helsinn Group Description and Business Overview

6.15.3 Helsinn Group Oral Mucositis Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Helsinn Group Oral Mucositis Drugs Product Portfolio

6.15.5 Helsinn Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Mucositis Drugs Industry Chain Analysis

7.2 Oral Mucositis Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Mucositis Drugs Production Mode & Process Analysis

7.4 Oral Mucositis Drugs Sales and Marketing

7.4.1 Oral Mucositis Drugs Sales Channels

7.4.2 Oral Mucositis Drugs Distributors

7.5 Oral Mucositis Drugs Customer Analysis

8 Oral Mucositis Drugs Market Dynamics

8.1 Oral Mucositis Drugs Industry Trends

8.2 Oral Mucositis Drugs Market Drivers

8.3 Oral Mucositis Drugs Market Challenges

8.4 Oral Mucositis Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Oral Mucositis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Oral Mucositis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Oral Mucositis Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Oral Mucositis Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Oral Mucositis Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Oral Mucositis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Oral Mucositis Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Oral Mucositis Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Oral Mucositis Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Mucositis Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Mucositis Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Oral Mucositis Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Mucositis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mucositis Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Mucositis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Oral Mucositis Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Oral Mucositis Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Oral Mucositis Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Oral Mucositis Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Oral Mucositis Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Oral Mucositis Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Oral Mucositis Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Oral Mucositis Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Oral Mucositis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Oral Mucositis Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Oral Mucositis Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Oral Mucositis Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Oral Mucositis Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Oral Mucositis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Oral Mucositis Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Oral Mucositis Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Oral Mucositis Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Oral Mucositis Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Oral Mucositis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Oral Mucositis Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Oral Mucositis Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Oral Mucositis Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Oral Mucositis Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oral Mucositis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Oral Mucositis Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Oral Mucositis Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Oral Mucositis Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral Mucositis Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Oral Mucositis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Oral Mucositis Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Oral Mucositis Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Oral Mucositis Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Oral Mucositis Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Oral Mucositis Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Oral Mucositis Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Oral Mucositis Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Oral Mucositis Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Oral Mucositis Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Oral Mucositis Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Oral Mucositis Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Oral Mucositis Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Oral Mucositis Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Oral Mucositis Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Oral Mucositis Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Oral Mucositis Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Oral Mucositis Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Oral Mucositis Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Oral Mucositis Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Oral Mucositis Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Oral Mucositis Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Oral Mucositis Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Oral Mucositis Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Oral Mucositis Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. 3M Healthcare Company Information

Table 71. 3M Healthcare Description and Business Overview

Table 72. 3M Healthcare Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. 3M Healthcare Oral Mucositis Drugs Product

Table 74. 3M Healthcare Recent Developments/Updates

Table 75. Haleon Company Information

Table 76. Haleon Description and Business Overview

Table 77. Haleon Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Haleon Oral Mucositis Drugs Product

Table 79. Haleon Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Pfizer Oral Mucositis Drugs Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Colgate-Palmolive Company Information

Table 86. Colgate-Palmolive Description and Business Overview

Table 87. Colgate-Palmolive Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Colgate-Palmolive Oral Mucositis Drugs Product

Table 89. Colgate-Palmolive Recent Developments/Updates

Table 90. Norgine Company Information

Table 91. Norgine Description and Business Overview

Table 92. Norgine Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Norgine Oral Mucositis Drugs Product

Table 94. Norgine Recent Developments/Updates

Table 95. Sobi Company Information

Table 96. Sobi Description and Business Overview

Table 97. Sobi Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Sobi Oral Mucositis Drugs Product

Table 99. Sobi Recent Developments/Updates

Table 100. Bausch Health Company Information

Table 101. Bausch Health Description and Business Overview

Table 102. Bausch Health Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Bausch Health Oral Mucositis Drugs Product

Table 104. Bausch Health Recent Developments/Updates

Table 105. EUSA Pharma Company Information

Table 106. EUSA Pharma Description and Business Overview

Table 107. EUSA Pharma Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. EUSA Pharma Oral Mucositis Drugs Product

Table 109. EUSA Pharma Recent Developments/Updates

Table 110. Camurus Company Information

Table 111. Camurus Description and Business Overview

Table 112. Camurus Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Camurus Oral Mucositis Drugs Product

Table 114. Camurus Recent Developments/Updates

Table 115. Clinigen Group Company Information

Table 116. Clinigen Group Description and Business Overview

Table 117. Clinigen Group Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Clinigen Group Oral Mucositis Drugs Product

Table 119. Clinigen Group Recent Developments/Updates

Table 120. Helsinn Healthcare Company Information

Table 121. Helsinn Healthcare Description and Business Overview

Table 122. Helsinn Healthcare Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Helsinn Healthcare Oral Mucositis Drugs Product

Table 124. Helsinn Healthcare Recent Developments/Updates

Table 125. Alliance Pharma Company Information

Table 126. Alliance Pharma Description and Business Overview

Table 127. Alliance Pharma Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Alliance Pharma Oral Mucositis Drugs Product

Table 129. Alliance Pharma Recent Developments/Updates

Table 130. Amgen Company Information

Table 131. Amgen Description and Business Overview

Table 132. Amgen Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Amgen Oral Mucositis Drugs Product

Table 134. Amgen Recent Developments/Updates

Table 135. Galera Therapeutics Company Information

Table 136. Galera Therapeutics Description and Business Overview

Table 137. Galera Therapeutics Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Galera Therapeutics Oral Mucositis Drugs Product

Table 139. Galera Therapeutics Recent Developments/Updates

Table 140. Helsinn Group Company Information

Table 141. Helsinn Group Description and Business Overview

Table 142. Helsinn Group Oral Mucositis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Helsinn Group Oral Mucositis Drugs Product

Table 144. Helsinn Group Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Oral Mucositis Drugs Distributors List

Table 148. Oral Mucositis Drugs Customers List

Table 149. Oral Mucositis Drugs Market Trends

Table 150. Oral Mucositis Drugs Market Drivers

Table 151. Oral Mucositis Drugs Market Challenges

Table 152. Oral Mucositis Drugs Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oral Mucositis Drugs

Figure 2. Global Oral Mucositis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Mucositis Drugs Market Share by Type: 2024 & 2031

Figure 4. Mouthwash Product Picture

Figure 5. Pain Control Medication Product Picture

Figure 6. Other Product Picture

Figure 7. Global Oral Mucositis Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Oral Mucositis Drugs Market Share by Application: 2024 & 2031

Figure 9. Chemotherapy

Figure 10. Radiotherapy

Figure 11. Global Oral Mucositis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Oral Mucositis Drugs Market Size (2020-2031) & (US$ Million)

Figure 13. Global Oral Mucositis Drugs Sales (2020-2031) & (K Units)

Figure 14. Global Oral Mucositis Drugs Average Price (US$/Unit) & (2020-2031)

Figure 15. Oral Mucositis Drugs Report Years Considered

Figure 16. Oral Mucositis Drugs Sales Share by Manufacturers in 2024

Figure 17. Global Oral Mucositis Drugs Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Oral Mucositis Drugs Players: Market Share by Revenue in Oral Mucositis Drugs in 2024

Figure 19. Oral Mucositis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Oral Mucositis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Oral Mucositis Drugs Sales Market Share by Country (2020-2031)

Figure 22. North America Oral Mucositis Drugs Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Oral Mucositis Drugs Sales Market Share by Country (2020-2031)

Figure 26. Europe Oral Mucositis Drugs Revenue Market Share by Country (2020-2031)

Figure 27. Germany Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Oral Mucositis Drugs Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Oral Mucositis Drugs Revenue Market Share by Region (2020-2031)

Figure 34. China Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Oral Mucositis Drugs Sales Market Share by Country (2020-2031)

Figure 45. Latin America Oral Mucositis Drugs Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Oral Mucositis Drugs Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Oral Mucositis Drugs Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Oral Mucositis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Oral Mucositis Drugs by Type (2020-2031)

Figure 55. Global Revenue Market Share of Oral Mucositis Drugs by Type (2020-2031)

Figure 56. Global Oral Mucositis Drugs Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Oral Mucositis Drugs by Application (2020-2031)

Figure 58. Global Revenue Market Share of Oral Mucositis Drugs by Application (2020-2031)

Figure 59. Global Oral Mucositis Drugs Price (US$/Unit) by Application (2020-2031)

Figure 60. Oral Mucositis Drugs Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Oral Mucositis Drugs market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Oral Mucositis Drugs market is 7.5% 2025 to 2031.

What was the global market size of Oral Mucositis Drugs in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Oral Mucositis Drugs in 2025? shouQi

Which companies rank high in the global Oral Mucositis Drugs market? shouQi

Related Reports

Global Oral Mucositis Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oral Mucositis Drugs market size was US$ 1107 million in 2025 and is forecast to reach a readjusted size of US$ 1823 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 97
USD 4250.00
(Single User License)
Global Oral Mucositis Drugs Market Research Report 2026
The global Oral Mucositis Drugs market was valued at US$ 1107 million in 2025 and is anticipated to reach US$ 1823 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 127
USD 2900.00
(Single User License)
Oral Mucositis Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oral Mucositis Drugs was estimated to be worth US$ 1107 million in 2025 and is projected to reach US$ 1823 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Oral Mucositis Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oral Mucositis Drugs market is projected to grow from US$ 1037 million in 2024 to US$ 1708 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 154
USD 4900.00
(Single User License)
Global Oral Mucositis Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oral Mucositis Drugs was estimated to be worth US$ 1037 million and is forecast to reach approximately US$ 1708 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 146
USD 5900.00
(Single User License)
Global Oral Mucositis Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oral Mucositis Drugs market size was US$ 1037 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
Oral Mucositis Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oral Mucositis Drugs was estimated to be worth US$ 1037 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 127
USD 3950.00
(Single User License)
Global Oral Mucositis Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Published Date: 2024-04-17
Pages: 155
USD 5600.00
(Single User License)
Global Oral Mucositis Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Published Date: 2024-04-16
Pages: 148
USD 5900.00
(Single User License)
Global Oral Mucositis Drugs Market Insights, Forecast to 2030
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)

Global Oral Mucositis Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oral Mucositis Drugs market size was US$ 1107 million in 2025 and is forecast to reach a readjusted size of US$ 1823 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 97
USD 4250.00 (Single User License)
Global Oral Mucositis Drugs Market Research Report 2026
The global Oral Mucositis Drugs market was valued at US$ 1107 million in 2025 and is anticipated to reach US$ 1823 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 127
USD 2900.00 (Single User License)
Oral Mucositis Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oral Mucositis Drugs was estimated to be worth US$ 1107 million in 2025 and is projected to reach US$ 1823 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)
Global Oral Mucositis Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oral Mucositis Drugs market is projected to grow from US$ 1037 million in 2024 to US$ 1708 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 154
USD 4900.00 (Single User License)
Global Oral Mucositis Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oral Mucositis Drugs was estimated to be worth US$ 1037 million and is forecast to reach approximately US$ 1708 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 146
USD 5900.00 (Single User License)
Global Oral Mucositis Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oral Mucositis Drugs market size was US$ 1037 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
USD 4250.00 (Single User License)
Oral Mucositis Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oral Mucositis Drugs was estimated to be worth US$ 1037 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 127
USD 3950.00 (Single User License)
Global Oral Mucositis Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Published: 2024-04-17
Pages: 155
USD 5600.00 (Single User License)
Global Oral Mucositis Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Published: 2024-04-16
Pages: 148
USD 5900.00 (Single User License)
Global Oral Mucositis Drugs Market Insights, Forecast to 2030
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Published: 2024-04-07
Pages: 105
USD 4900.00 (Single User License)